Showing results (1281-1290 of 5,986) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|August 1, 2012
PKCδ regulates death receptor 5 expression induced by PS-341 through ATF4-ATF3/CHOP axis in human lung cancer cellsLinyan Xu, Ling Su, Xiangguo Liu
Molecular Cancer Therapeutics|August 7, 2012
A cell-penetrating bispecific antibody for therapeutic regulation of intracellular targetsRichard H Weisbart, Joseph F Gera, Grace Chan, et al.
Molecular Cancer Therapeutics|August 24, 2012
Targeting the apoptotic pathway in chondrosarcoma using recombinant human Apo2L/TRAIL (dulanermin), a dual proapoptotic receptor (DR4/DR5) agonistVivek Subbiah, Robert E Brown, Jamie Buryanek, et al.
Molecular Cancer Therapeutics|August 31, 2012
Perillyl alcohol for the treatment of temozolomide-resistant gliomasHee-Yeon Cho, Weijun Wang, Niyati Jhaveri, et al.
Molecular Cancer Therapeutics|August 31, 2012
Stromal platelet-derived growth factor receptor α (PDGFRα) provides a therapeutic target independent of tumor cell PDGFRα expression in lung cancer xenograftsDavid E Gerber, Puja Gupta, Michael T Dellinger, et al.
Molecular Cancer Therapeutics|August 31, 2012
Drug resistance to inhibitors of the human double minute-2 E3 ligase is mediated by point mutations of p53, but can be overcome with the p53 targeting agent RITARichard J Jones, Chad C Bjorklund, Veerabhadran Baladandayuthapani, et al.
Molecular Cancer Therapeutics|August 31, 2012
Selective targeting of interferon γ to stromal fibroblasts and pericytes as a novel therapeutic approach to inhibit angiogenesis and tumor growthRuchi Bansal, Tushar Tomar, Arne Ostman, et al.
Molecular Cancer Therapeutics|August 8, 2012
Humanization of an anti-CCR4 antibody that kills cutaneous T-cell lymphoma cells and abrogates suppression by T-regulatory cellsDe-Kuan Chang, Jianhua Sui, Shusheng Geng, et al.
Molecular Cancer Therapeutics|August 11, 2012
Discordant cellular response to presurgical letrozole in bilateral synchronous ER+ breast cancers with a KRAS mutation or FGFR1 gene amplificationJustin M Balko, Ingrid A Mayer, Melinda E Sanders, et al.
Molecular Cancer Therapeutics|September 14, 2012
Deficient DNA damage signaling leads to chemoresistance to cisplatin in oral cancerLing Wang, Adam J Mosel, Gregory G Oakley, et al.
Pageof 599